Parthenolide enhances the metronomic chemotherapy effect of cyclophosphamide in lung cancer by inhibiting the NF-kB signaling pathway

Figure 3 Survival analysis of tumor-bearing mice. A: Animal experiment process; B: Survival curve and log-rank analysis of 4 groups of tumor-bearing mice; C: Survival comparison between control and parthenolide (PTL) groups; D: Survival comparison between control and cyclophosphamide (CTX) chemotherapy groups; E: Comparison between CTX and PTL + CTX combined groups; F: Tumor growth curve of different groups; G: Comparison of tumor growth rate. n = 10, ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. NS: Not significant; PTL: Parthenolide; CTX: Cyclophosphamide.